SkinCeuticals will soon unveil its Redness Neutralizer, a lightweight gel cream that prevents redness by targeting environmental triggers of inflammation leading to the onset of rosacea. Formulated with patent-pending NeuroMed Complex, a combination of biomimetic peptides and natural actives that combats stages of the inflammation cascade, Redness Neutralizer reduces skin hyper-reactivity to the environmental assaults that trigger redness and flushing, the company says. In a recent 12-week trial, redness and flushing were reduced by 30 percent, radiance improved over 30 percent, and skin smoothness improved over 55 percent. Redness Neutralizer will be available in March. SkinCeuticals.com